232 related articles for article (PubMed ID: 32596207)
41. Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative.
Tomoshige S; Nomura S; Ohgane K; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2018 Feb; 28(4):707-710. PubMed ID: 29366651
[TBL] [Abstract][Full Text] [Related]
42. Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation.
Howard RA; Sharma P; Hajjar C; Caldwell KA; Caldwell GA; du Breuil R; Moore R; Boyd L
BMC Cell Biol; 2007 Jul; 8():32. PubMed ID: 17663792
[TBL] [Abstract][Full Text] [Related]
43. Global changes to the ubiquitin system in Huntington's disease.
Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
[TBL] [Abstract][Full Text] [Related]
44. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
45. The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.
Wanker EE; Ast A; Schindler F; Trepte P; Schnoegl S
J Neurochem; 2019 Nov; 151(4):507-519. PubMed ID: 31418858
[TBL] [Abstract][Full Text] [Related]
46. Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.
Zhu Y; Li C; Tao X; Brazill JM; Park J; Diaz-Perez Z; Zhai RG
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19165-19175. PubMed ID: 31484760
[TBL] [Abstract][Full Text] [Related]
47. Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane.
Swaih AM; Breda C; Sathyasaikumar KV; Allcock N; Collier MEW; Mason RP; Feasby A; Herrera F; Outeiro TF; Schwarcz R; Repici M; Giorgini F
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140394
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional Regulation of the Huntingtin Gene.
Thomson SB; Leavitt BR
J Huntingtons Dis; 2018; 7(4):289-296. PubMed ID: 30452421
[TBL] [Abstract][Full Text] [Related]
49. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
Akbergenova Y; Littleton JT
J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
[TBL] [Abstract][Full Text] [Related]
50. Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight.
Gopalakrishnan C; Jethi S; Kalsi N; Purohit R
Cell Biochem Biophys; 2016 Jun; 74(2):129-39. PubMed ID: 27094178
[TBL] [Abstract][Full Text] [Related]
51. Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease.
Skogen M; Roth J; Yerkes S; Parekh-Olmedo H; Kmiec E
BMC Neurosci; 2006 Oct; 7():65. PubMed ID: 17014717
[TBL] [Abstract][Full Text] [Related]
52. High-Throughput Multiplexed Quantitation of Protein Aggregation and Cytotoxicity in a Huntington's Disease Model.
Titus SA; Southall N; Marugan J; Austin CP; Zheng W
Curr Chem Genomics; 2012; 6():79-86. PubMed ID: 23346268
[TBL] [Abstract][Full Text] [Related]
53. PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An
Carnemolla A; Michelazzi S; Agostoni E
Front Cell Neurosci; 2017; 11():121. PubMed ID: 28533744
[TBL] [Abstract][Full Text] [Related]
54. Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease.
Imbert M; Blandel F; Leumann C; Garcia L; Goyenvalle A
Nucleic Acid Ther; 2019 Oct; 29(5):256-265. PubMed ID: 31184975
[TBL] [Abstract][Full Text] [Related]
55. Optimization of
Rindt H; Tom CM; Lorson CL; Mattis VB
Front Neurosci; 2017; 11():544. PubMed ID: 29066943
[TBL] [Abstract][Full Text] [Related]
56. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
57. Role of chaperone-mediated autophagy in degrading Huntington's disease-associated huntingtin protein.
Qi L; Zhang XD
Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):83-91. PubMed ID: 24323530
[TBL] [Abstract][Full Text] [Related]
58. Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients.
Pierzynowska K; Gaffke L; Cyske Z; Węgrzyn G
Metab Brain Dis; 2019 Jun; 34(3):715-720. PubMed ID: 30850940
[TBL] [Abstract][Full Text] [Related]
59. Aggregation in Huntington's disease: insights through modelling.
Cajavec B; Bernard S; Herzel H
Genome Inform; 2005; 16(1):262-71. PubMed ID: 16362929
[TBL] [Abstract][Full Text] [Related]
60. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
Wong HK; Bauer PO; Kurosawa M; Goswami A; Washizu C; Machida Y; Tosaki A; Yamada M; Knöpfel T; Nakamura T; Nukina N
Hum Mol Genet; 2008 Oct; 17(20):3223-35. PubMed ID: 18658163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
